Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.2 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.2 |
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.2 |
mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |